ABSTRACr Based upon its ability to inhibit opiate receptor binding, a low-molecular-weight substance (600) has been isolated from human plasma by extraction into butanol and ion exchange, molecular sieve, and thin-layer chromatography. When this substance, termed anodynin, is microiniected into rat periaqueductal gray matter, it causes a profound, onglasting analgesia which is prevented by prior injection of the opiate antagonist naloxone. Anodynin (opiate receptor binding material) levels in serum from hyDophysectomized rats are less than 5% of values obtained in sham-operated controls. Anodynin differs from enkephalin, a morphine-like peptide isolated from brain, in its sensitivity to enzymatic loss of opiate receptor inhibitory potency, thin-layer chromatographic mobility, and behavioral effects. Anodynin might be a hormone that acts on peripheral opiate receptors in the classical manner, but might also, due to its lipophilic nature and small size, penetrate into the brain to produce centrally mediated behavioral effects.
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Opiate receptors are hypothetical stereospecific tissue constituents with which morphine and other opiate agonists complex to initiate their pharmacological effects (1, 2) . Specific binding of radiolabeled opiates to nervous tissue homogenates having a number of features expected of pharmacologically relevant drug receptors has been demonstrated (3) (4) (5) and studied extensively (6, 7) . Presumably, opiate receptors, which are localized on the synaptic membrane (8) of certain discrete brain areas (9) (10) (11) , participate in some normal physiological function even when the organism is not exposed to opiates. The rather strict structural requirements for opiate activity have suggested to some investigators (12) (13) (14) that opiate receptors normally interact with some naturally occurring "endogenous ligand" for which morphine and its congeners provide structural analogues.
Recently Hughes and his associates (15) have isolated two pentapeptides from porcine brain on the basis of their morphine-like effects on the mouse vas deferens and guinea pig ileum. They have termed these peptides "enkephalin," assigned them structures, and demonstrated that synthetic enkephalin is pharmacologically active (16) . Snyder and his associates (17) and Terenius and Wahlstrom (18) have also isolated morphine-like peptides from mammalian brain, using their affinity for opiate receptors in vitro as the basis of their purification.
The endogenous ligand located in the central nervous system might function as a neuromodulator (19) or a neurotransmitter, for which the opiate receptor is a post-synaptic recognition unit which alters sodium ion conductance (6, 7) . An additional function has been proposed by Goldstein and his collaborators, who have isolated a larger morphine-like peptide from bovine pituitary (20, 21) and suggested that it may be stored and released from pituitary and act at remote opiate-sensitive tissues in the manner of a typical pituitary hormone.
We now report the isolation of "anodynin," a small peptide from human blood that has a high affinity for opiate receptors in vitro. The peptide, which is not enkephalin, produces profound and long-lasting analgesia and sedation in rats, which is reversed by the opiate antagonist naloxone. Levels of anodynin-like receptor inhibitory activity are greatly diminished in rat blood after hypophysectomy.
MATERIALS AND METHODS
Preparation from Human Blood. Outdated human plasma, which had been refrigerated for several weeks after removal of blood cells by centrifugation at 600 X g, was obtained from the National Institutes of Health Blood Bank. Batches of about 1 liter were adjusted to pH 3 with HC1 and heated in a boiling-water bath, and the resultant precipitate was removed by low-speed centrifugation. After pH adjustment to 9.0 by Tris base, the supernatant fluid and precipitate were each extracted twice with approximately half volumes of water-saturated butanol. The clear yellow butanol extract was evaporated to dryness at 220 on a rotary evaporator. The resultant residue was dissolved in 50-100 ml of Tris-HCl buffer (0.05 M, pH 7.7 at 25°). After removal of undissolved material by low-speed centrifugation, the extract was applied to a column (20 cm X 4 cm) containing Dowex 1-X8 anion exchange resin (hydroxide form) (Baker Chemicals) and washed with Tris buffer (0.05 M, pH 7 .0 at 25°) until the effluent became colorless (about 200 ml). The resin was eluted batch-wise by mixing it in an equivalent volume of glycine-HCl buffer, pH 3.0. After lyophilization, the white residue was dissolved in 10-20 ml of Tris buffer (pH 7.4 at 370, 0.1 M) and filtered through a Millipore filter (45 ,um size) before application to a 80 cm X 5 cm column containing Bio-Gel P-2. The column was eluted with 2 liters of the same buffer at a flow rate of 50 ml/hr, and 15 X g, the membranes were reconstituted in standard buffer.
After recentrifugation, each brain was suspended in 10 ml of the standard buffer.
Aliquots of the freshly prepared membrane preparation (100 ,ul) were incubated for 1 hr at 00 with 100 mM NaCl in a final Proc. Natl. Acad. Sci. USA 73(1976) 2227 For preparation of endogenous inhibitor, each region was homogenized in 10 volumes of glycine.HCI buffer (0.05 M, pH = 3) and the supernatant fluid was extracted into butanol after boiling and adjustment to pH 9. Inhibition by 100 X of reconstituted extract was assessed after 60 min of incubation at 0°(NaCl = 100 mM). Values are mean 4 standard error of the mean (number of extracts). Opiate receptor content was assessed as described in Materials and Methods after dissection of specified regions. volume of 0.5 ml with [3H]naloxone (Amersham-Searle, 34 Ci/mmol) in a concentration of 1.3 nM (20,000 cpm). After rapid filtration and washing with two 7-ml portions of ice-cold standard buffer (4), membrane-laden filters were transferred and counted at 40-45% efficiency at least 6 
RESULTS

Purification
The major purification step is the efficient extraction into butanol, which removes most protein and yields a lipid-rich fraction. This step was suggested by the very hydrophobic nature of the preliminary amino acid content of enkephalin proposed by Hughes et al. (25) . Table 1 demonstrates that the butanol extraction procedure, when applied to rat brain, yields an endogenous inhibitor of opiate receptor binding which parallels the previously reported (3, 11) distribution of opiate receptor content in rat brain. This suggests that nonspecific interference in the opiate receptor assay has been minimized* in the chosen conditions, and the majority of inhibitory activity is associated with a specific opiate receptor ligand.
No opiate receptor inhibitory activity could be detected in any fraction of the neutral washes of the Dowex column to which butanol extracts of midbrain-striatum, cerebellum, or plasma had been applied. The acidic eluent of mid-brain striatum and plasma, but not cerebellum, demonstrated significant inhibition of [3H]naloxone binding after adjustment to neutrality. Molecular weight determination of the blood inhibitory substance (Fig. 1) indicates a molecular weight (600) which is not significantly different from that of synthetic enkephalin.
Thin-layer chromatographic analysis in chloroform-methanol-20% ammonia (60:30:5, vol/vol/vol) of the opiate receptor inhibitory activity pooled from fractions 86-110 of the Bio-Gel column revealed the presence of four spots (RF values = 0.17, 0.58, 0.67, and 0.91), none of which corresponded to either metor leu-enkephalin (RF = 0.47 and 0.48), which were chromatographed on the same plate (Fig. 2) . After elution of the spots, significant (>15%) opiate receptor inhibitory activity was found to reside only in the slow-moving spot with RF equal to 0.17. No significant opiate receptor inhibitory activity was detectable in the eluent of the area next to synthetic met-or leu-enkephalin. The isolated inhibitory blood factor was found to run as a single spot when eluted and rechromatographed in the same solvent system (RF = 0. 19 
Properties
The ability of the blood inhibitory factor eluted from the thin-layer plate to be degraded by enzymes present in brain was examined by incubating the blood substance with membranes or supernatant fluid from rat brain, terminating the enzyme action by boiling, and subsequently adding the product to the (Fig. 3 ) and other opiates (7). Behavioral effects Anodynin produced an immediate, profound, long-lasting analgesia as assessed by the rat "tail-flick" test (Fig. 4) . analysis of variance revealed a significant treatments effect (P (17) , is a useful method for assessing purification progress. While anodynin may be a close structural analog to enkephalin, it differs from it in its sensitivity to brain enzymatic degradation, its duration of analgesia, and its thin-layer mobility in three solvent systems. It has been shown previously (26) ephalin, which is rapidly destroyed in brain, requires doses at least 40 times higher than morphine to elicit analgesia, which disappears completely 1-2 min after microinjection. By contrast, anodynin appears to be relatively resistant to inactivation by brain enzymes in vitro and elicits naloxone-reversible analgesia which is, at low doses, only slightly diminished 1 hr after microinjection. Since this analgesia is blocked by naloxone, it is due to a specific interaction with brain opiate receptors and cannot be attributed to a nonspecific incapacitation of the animals.
The fact that several peptides exist, the enkephalins in porcine brain and anodynin in human blood, could have functional significance or could be attributed to species differences. In any case, it is highly unlikely that anodynin is a degradation product of enkephalin or vice versa, since neither substance gives evidence of the generation of the other upon repeated thin-layer chromatographic analysis and storage.
Since hypophysectomy almost completely abolishes blood anodynin, it may be concluded that anodynin is stored in and released from the pituitary in the manner of classical hormones, Butanol extracts of blood serum were prepared as in the Materials and Methods, and aliquots from each sample (150 il) were assayed for opiate receptor inhibition, as described. Morphine inhibitory equivalence was calculated from Fig. 3 . The decrease in anodynin levels in hypophysectomized rats is significant (P < 0.02).
Biochemistry: Pert et al. Proc. Nati. Acad. Sci. USA 73 (1976) or that a pituitary factor is required for its maintenance. Goldstein and coworkers (20, 21) originally suggested the possibility of a morphine-like hormone, based upon their purification from bovine pituitary of a higher molecular weight peptide with morphine-like properties (POP-1). The relationship between POP-1, which may be a hormone precursor, and anodynin is unclear. In addition, Hughes et al. (16) have drawn attention to the fact that the enkephalin peptide sequence is contained within the structure of the high-molecular-weight fl-lipotropin (26) . Anodynin, with its low molecular weight and high butanol solubility, is clearly not jl-lipotropin; fl-lipotropin might, however, be a prohormone for anodynin or POP-1. Since "raw" plasma contains many substances that interfere in the opiate receptor binding assay, including adrenocorticotrophic hormones (28) , and cannot be directly assayed, estimation of recovery of the purification procedure is not possible. It should be noted that the possibility of other morphine-like substances' existing in blood cannot be rigorously excluded. However, if enkephalin were present in rat or human blood, its physiocochemical properties make it likely that it would have been purified with anodynin in our procedure.
The physiological function of circulating blood anodynin hopefully will be elucidated by comparison of levels in various normal and pathological states. The unperturbed levels obtained in plasma of normal rats are sufficient to maintain peripheral opiate receptors in a state of slightly more than half saturation, presuming they are in equilibrium with plasma. In addition, because of its hydrophobic nature, anodynin may pass into the brain after release from the pituitary via the blood circulation and thus produce centrally mediated behavioral effects such as analgesia, sleepiness, or euphoria.
